Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesPreferred Shares IssuedSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Albemarle (ALB-PA) Gains from Investment Securities (2016 - 2025)

Albemarle's Gains from Investment Securities history spans 17 years, with the latest figure at $7.1 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 103.05% year-over-year to $7.1 million; the TTM value through Dec 2025 reached $7.3 million, down 93.74%, while the annual FY2025 figure was $7.3 million, 93.74% down from the prior year.
  • Gains from Investment Securities reached $7.1 million in Q4 2025 per ALB-PA's latest filing, up from -$67.6 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $426.7 million in Q2 2025 to a low of -$359.0 million in Q1 2025.
  • Average Gains from Investment Securities over 5 years is -$1.3 million, with a median of $1.2 million recorded in 2023.
  • Peak YoY movement for Gains from Investment Securities: surged 2796.84% in 2023, then plummeted 19460.25% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$47.4 million in 2021, then tumbled by 103.12% to -$96.3 million in 2022, then surged by 101.25% to $1.2 million in 2023, then tumbled by 19460.25% to -$232.3 million in 2024, then surged by 103.05% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for ALB-PA's Gains from Investment Securities are $7.1 million (Q4 2025), -$67.6 million (Q3 2025), and $426.7 million (Q2 2025).